These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2199223)
1. Current status of immunoscintigraphy in colorectal cancer--results of 5 years' clinical experiences. Hölting T; Schlag P; Georgi P Eur J Surg Oncol; 1990 Aug; 16(4):312-8. PubMed ID: 2199223 [TBL] [Abstract][Full Text] [Related]
2. The value of immunoscintigraphy for the operative retreatment of colorectal cancer. Limitations of a new diagnostic method. Hölting T; Schlag P; Steinbächer M; Kretzschmar U; Georgi P; Herfarth C Cancer; 1989 Aug; 64(4):830-3. PubMed ID: 2743277 [TBL] [Abstract][Full Text] [Related]
3. [Does immunoscintigraphy improve early diagnosis of metastatic or recurrent cancer?]. Hölting T; Steinbächer M; Kretzschmar U; Georgi P; Schlag P Onkologie; 1989 Aug; 12 Suppl 1():20-5. PubMed ID: 2685691 [TBL] [Abstract][Full Text] [Related]
4. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer]. Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746 [TBL] [Abstract][Full Text] [Related]
7. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma? Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871 [TBL] [Abstract][Full Text] [Related]
8. [Clinical relevance of immunoscintigraphy with 99mTc-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of surgical resectability with a combination of conventional imaging methods]. Behr TM; Goldenberg DM; Scheele JR; Wolf FG; Becker W Dtsch Med Wochenschr; 1997 Apr; 122(15):463-70. PubMed ID: 9147937 [TBL] [Abstract][Full Text] [Related]
9. Immunoscintigraphy of colorectal carcinomas with radiolabeled monoclonal antibody fragments. Obradovic V; Artiko V; Petrovic M; Stefanovic B; Krivokapic Z; Zuvela M; Stojkovic M; Stefanovic B; Milovanovic A; Vlajkovic M Hepatogastroenterology; 2006; 53(70):526-30. PubMed ID: 16995454 [TBL] [Abstract][Full Text] [Related]
10. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up. Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193 [TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA. Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer]. García Vicente A; Soriano Castrejón A; González R; Rodado Marina S; Poblete García VM Rev Esp Med Nucl; 2002; 21(5):349-55. PubMed ID: 12236910 [TBL] [Abstract][Full Text] [Related]
13. [Current role of immunoscintigraphy for surgical therapy of the recurrence of colorectal cancers]. Schlag P; Hölting T; Steinbächer M; Kretzschmar U; Georgi P Chirurg; 1987 Sep; 58(9):594-6. PubMed ID: 3677890 [TBL] [Abstract][Full Text] [Related]
15. [Clinical application of radioimmunolocalization in colorectal cancer]. Germà JR; Alvarez I; Carrió I; Estorch M; Bernà L; Martínez-Duncker C; Marcuello E; Nogueras FM Med Clin (Barc); 1990 Mar; 94(9):325-8. PubMed ID: 2329866 [TBL] [Abstract][Full Text] [Related]
16. The value of immunoscintigraphy in the detection of recurrent colorectal cancer. Baulieu F; Bourlier P; Scotto B; Mor C; Eder V; Picon L; De Calan L; Dorval E; Pottier JM; Baulieu JL Nucl Med Commun; 2001 Dec; 22(12):1295-304. PubMed ID: 11711899 [TBL] [Abstract][Full Text] [Related]
17. Imaging of pancreatic and colorectal cancer using antibody fragments: a preliminary evaluation. Ballantyne KC; Perkins AC; Selby C; Wastie ML; Hardcastle JD Eur J Surg Oncol; 1988 Oct; 14(5):393-8. PubMed ID: 3181442 [TBL] [Abstract][Full Text] [Related]
18. [The value of CEA immunoscintigraphy for diagnosis of colorectal cancer and its metastases: results of a prospective study]. Imdahl A; Bräutigam P; Hauenstein KH; Eggstein S; Waninger J; Farthmann EH Zentralbl Chir; 1994; 119(1):17-22. PubMed ID: 8147155 [TBL] [Abstract][Full Text] [Related]
19. [Immunoscintigraphy in colorectal cancers from the viewpoint of the gastroenterologist]. Dippold WG; Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH Z Gastroenterol; 1990 Dec; 28(12):673-7. PubMed ID: 2087823 [TBL] [Abstract][Full Text] [Related]
20. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma. Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]